Black Horse Investments
Black Horse Investments is a private investment fund focused on commercial development and investing. The firm seeks opportunities to engage in various investment projects, aiming to generate sustainable returns through strategic asset management and development initiatives. By concentrating on commercial ventures, Black Horse Investments plays a significant role in fostering economic growth and enhancing community infrastructure.
1 past transactions
Promentis Pharmaceuticals
Series B in 2014
Promentis Pharmaceuticals, Inc. is a biopharmaceutical company based in Milwaukee, Wisconsin, that specializes in developing therapies for neuropsychiatric disorders. Founded in 2006, the company focuses on creating innovative treatments that target the central nervous system, specifically addressing glutamatergic imbalance and oxidative stress, which are critical factors in various psychiatric conditions. Promentis is known for its lead compound, SXC-2023, and other therapeutic candidates aimed at treating disorders such as impulse control disorders and obsessive-compulsive disorder, as well as exploring solutions for schizophrenia. The company's goal is to restore proper neurotransmission and improve cortical function, ultimately enhancing treatment options for individuals suffering from these debilitating conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.